BioSpace News Archive

B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system.

Proton Partners International Limited, has placed an order for the treatment planning system RayStation®.

Novocure announced that Bill Doyle, Novocure’s Executive Chairman, will participate in the Jefferies 2019 Global Healthcare Conference on June 4, 2019, in New York City.

Bristol-Myers Squibb Company announced the extension of the expiration date of the offers to exchange notes issued by Celgene Corporation for up to $19,850,000,000 aggregate principal amount of new notes to be issued by Bristol-Myers Squibb Company and cash and the related consent solicitations being made by Bristol-Myers Squibb on behalf of Celgene to adopt certain proposed amendments to the indentures governing the Celgene Notes.

Kelyniam Global, a maker of custom cranial and craniofacial implants, announced that it has received premarket approval from the Food and Drug Administration for a new 510 application that allows for unique modifications to their PEEK cranio-maxillofacial implant product line.

IBE President Dr. Martin Brodie Receives Epilepsy Lifetime Accelerator Award at AEDD

Name Reflects Our Focus on Defeating Cancer and Allergic Inflammatory Diseases

According to the Illinois Semi Truck Accident Victims Center, “So far this year victims of commercial truck accidents and pedestrians hit by vehicles are the leading groups for traffic fatalities in Illinois.

Former One Medical and Galileo executive brings extensive clinical leadership to the mission-driven virtual care company

The global antifreeze proteins market is expected to post a CAGR of more than 30% during the period 2019-2023, according to the latest market research report by Technavio.